- Home
- OPTX vs STTK Comparison
OPTX vs STTK Comparison
Compare OPTX & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- STTK
- Stock Information
- Founded
- OPTX 1981
- STTK 2016
- Country
- OPTX United States
- STTK United States
- Employees
- OPTX N/A
- STTK N/A
- Industry
- OPTX Blank Checks
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- STTK Health Care
- Exchange
- OPTX Nasdaq
- STTK Nasdaq
- Market Cap
- OPTX 51.9M
- STTK 59.7M
- IPO Year
- OPTX N/A
- STTK 2020
- Fundamental
- Price
- OPTX $0.88
- STTK $1.01
- Analyst Decision
- OPTX
- STTK Hold
- Analyst Count
- OPTX 0
- STTK 3
- Target Price
- OPTX N/A
- STTK $2.00
- AVG Volume (30 Days)
- OPTX 49.6K
- STTK 337.6K
- Earning Date
- OPTX 11-14-2024
- STTK 11-14-2024
- Dividend Yield
- OPTX N/A
- STTK N/A
- EPS Growth
- OPTX 81.79
- STTK N/A
- EPS
- OPTX 0.01
- STTK N/A
- Revenue
- OPTX $28,126,356.00
- STTK $6,435,000.00
- Revenue This Year
- OPTX N/A
- STTK $115.09
- Revenue Next Year
- OPTX N/A
- STTK N/A
- P/E Ratio
- OPTX $72.91
- STTK N/A
- Revenue Growth
- OPTX N/A
- STTK 382.75
- 52 Week Low
- OPTX $0.88
- STTK $0.99
- 52 Week High
- OPTX $8.39
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- OPTX 31.43
- STTK 29.62
- Support Level
- OPTX $0.88
- STTK $1.14
- Resistance Level
- OPTX $1.59
- STTK $1.19
- Average True Range (ATR)
- OPTX 0.11
- STTK 0.13
- MACD
- OPTX -0.07
- STTK 0.02
- Stochastic Oscillator
- OPTX 4.24
- STTK 0.00
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.